Systemic lupus erythematosus presenting as myelofibrosis. 1998

K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
First Department of Internal Medicine, University of Athens School of Medicine, Greece.

Myelofibrosis is not frequent in systemic lupus erythematosus (SLE). A review in the literature reveals that the co-incidence is rather rare since there are only a few papers reporting this combination. The female patient described hereby, presented with thrombocytopenia; following investigation, the diagnosis of SLE was established and bone marrow examination revealed an increase of marrow reticulin. Treatment with steroids reversed both thrombocytopenia and bone marrow fibrosis.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D055728 Primary Myelofibrosis A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone. Agnogenic Myeloid Metaplasia,Bone Marrow Fibrosis,Chronic Idiopathic Myelofibrosis,Fibrosis, Bone Marrow,Idiopathic Myelofibrosis,Myelofibrosis,Myelofibrosis With Myeloid Metaplasia,Myeloid Metaplasia,Myelosclerosis,Myelosis, Nonleukemic,Agnogenic Myeloid Metaplasias,Bone Marrow Fibroses,Fibroses, Bone Marrow,Metaplasia, Agnogenic Myeloid,Metaplasia, Myeloid,Metaplasias, Agnogenic Myeloid,Metaplasias, Myeloid,Myelofibroses,Myelofibroses, Primary,Myelofibrosis, Primary,Myeloid Metaplasia, Agnogenic,Myeloid Metaplasias,Myeloid Metaplasias, Agnogenic,Myeloscleroses,Myeloses, Nonleukemic,Nonleukemic Myeloses,Nonleukemic Myelosis,Primary Myelofibroses

Related Publications

K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
August 1992, The Journal of rheumatology,
K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
July 2019, The American journal of case reports,
K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
November 1986, The American journal of medicine,
K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
November 2000, Leukemia & lymphoma,
K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
December 1993, The Journal of rheumatology,
K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
September 1989, Clinical rheumatology,
K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
October 2015, The Journal of the Association of Physicians of India,
K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
April 1978, Archives of disease in childhood,
K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
April 1994, British journal of rheumatology,
K Konstantopoulos, and E Terpos, and H Prinolakis, and A Kanta, and E Variami, and G Kanellopoulou, and G Vaiopoulos, and A Floros, and A Androulaki, and J Meletis
May 2023, The primary care companion for CNS disorders,
Copied contents to your clipboard!